| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 9.51e-06 | 5 | 20 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 3.30e-04 | 27 | 20 | 2 | GO:0017134 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor apoptotic signaling pathway | 2.68e-06 | 3 | 20 | 2 | GO:1902178 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic nuclear division | 3.13e-05 | 64 | 20 | 3 | GO:0045839 | |
| GeneOntologyBiologicalProcess | negative regulation of nuclear division | 4.64e-05 | 73 | 20 | 3 | GO:0051784 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 5.04e-05 | 75 | 20 | 3 | GO:0048286 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation in bone marrow | 5.86e-05 | 12 | 20 | 2 | GO:0071864 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipase activity | 8.07e-05 | 14 | 20 | 2 | GO:0010518 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.02e-04 | 95 | 20 | 3 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of cell proliferation in bone marrow | 1.06e-04 | 16 | 20 | 2 | GO:0071863 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.12e-04 | 98 | 20 | 3 | GO:1902099 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 1.16e-04 | 854 | 20 | 6 | GO:1903047 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.19e-04 | 100 | 20 | 3 | GO:0007091 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.30e-04 | 103 | 20 | 3 | GO:0044784 | |
| GeneOntologyBiologicalProcess | cell proliferation in bone marrow | 1.35e-04 | 18 | 20 | 2 | GO:0071838 | |
| GeneOntologyBiologicalProcess | vasculogenesis involved in coronary vascular morphogenesis | 1.35e-04 | 18 | 20 | 2 | GO:0060979 | |
| GeneOntologyBiologicalProcess | lens fiber cell development | 1.35e-04 | 18 | 20 | 2 | GO:0070307 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle | 1.39e-04 | 282 | 20 | 4 | GO:0045930 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.62e-04 | 111 | 20 | 3 | GO:0033045 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 1.77e-04 | 1342 | 20 | 7 | GO:0033043 | |
| GeneOntologyBiologicalProcess | regulation of phospholipase activity | 2.04e-04 | 22 | 20 | 2 | GO:0010517 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | 2.11e-04 | 594 | 20 | 5 | GO:0007346 | |
| GeneOntologyBiologicalProcess | positive regulation of lipase activity | 2.64e-04 | 25 | 20 | 2 | GO:0060193 | |
| GeneOntologyBiologicalProcess | regulation of mitotic nuclear division | 2.82e-04 | 134 | 20 | 3 | GO:0007088 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 2.97e-04 | 1014 | 20 | 6 | GO:0000278 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 3.14e-04 | 139 | 20 | 3 | GO:0051983 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | 3.62e-04 | 362 | 20 | 4 | GO:0010948 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 4.92e-04 | 34 | 20 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 5.85e-04 | 172 | 20 | 3 | GO:0051783 | |
| GeneOntologyBiologicalProcess | endochondral bone growth | 6.48e-04 | 39 | 20 | 2 | GO:0003416 | |
| GeneOntologyBiologicalProcess | regulation of lipase activity | 7.16e-04 | 41 | 20 | 2 | GO:0060191 | |
| GeneOntologyBiologicalProcess | lens fiber cell differentiation | 8.25e-04 | 44 | 20 | 2 | GO:0070306 | |
| GeneOntologyBiologicalProcess | bone growth | 8.62e-04 | 45 | 20 | 2 | GO:0098868 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | 9.20e-04 | 464 | 20 | 4 | GO:0045786 | |
| GeneOntologyBiologicalProcess | biomineral tissue development | 9.46e-04 | 203 | 20 | 3 | GO:0031214 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | 1.06e-03 | 845 | 20 | 5 | GO:0010564 | |
| GeneOntologyBiologicalProcess | digestive tract morphogenesis | 1.48e-03 | 59 | 20 | 2 | GO:0048546 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 1.58e-03 | 61 | 20 | 2 | GO:0060428 | |
| GeneOntologyBiologicalProcess | regulation of epidermal cell differentiation | 1.68e-03 | 63 | 20 | 2 | GO:0045604 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.80e-03 | 254 | 20 | 3 | GO:0000819 | |
| GeneOntologyBiologicalProcess | cell cycle process | 1.90e-03 | 1441 | 20 | 6 | GO:0022402 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.06e-03 | 266 | 20 | 3 | GO:0033044 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 2.12e-03 | 269 | 20 | 3 | GO:0002064 | |
| GeneOntologyBiologicalProcess | lung development | 2.12e-03 | 269 | 20 | 3 | GO:0030324 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 2.13e-03 | 71 | 20 | 2 | GO:0045682 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 2.21e-03 | 273 | 20 | 3 | GO:0030323 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.80e-03 | 1053 | 20 | 5 | GO:0000122 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 2.90e-03 | 83 | 20 | 2 | GO:0060976 | |
| HumanPheno | Duplication of the distal phalanx of the hallux | 2.54e-05 | 4 | 11 | 2 | HP:0010084 | |
| HumanPheno | Duplication of distal phalanx of toe | 2.54e-05 | 4 | 11 | 2 | HP:0010193 | |
| HumanPheno | Hypoplasia of the lacrimal punctum | 2.54e-05 | 4 | 11 | 2 | HP:0007892 | |
| HumanPheno | Lacrimal gland aplasia | 2.54e-05 | 4 | 11 | 2 | HP:0007656 | |
| HumanPheno | Short middle phalanx of toe | 4.22e-05 | 5 | 11 | 2 | HP:0003795 | |
| HumanPheno | Increased corneal thickness | 4.22e-05 | 5 | 11 | 2 | HP:0011487 | |
| HumanPheno | Decreased corneal sensation | 4.22e-05 | 5 | 11 | 2 | HP:0012155 | |
| HumanPheno | Proximal radio-ulnar synostosis | 6.33e-05 | 6 | 11 | 2 | HP:0005037 | |
| HumanPheno | Mixed hearing impairment | 7.09e-05 | 40 | 11 | 3 | HP:0000410 | |
| HumanPheno | Prominent crus of helix | 8.85e-05 | 7 | 11 | 2 | HP:0009899 | |
| HumanPheno | Absent lacrimal punctum | 8.85e-05 | 7 | 11 | 2 | HP:0001092 | |
| HumanPheno | Abnormal lacrimal punctum morphology | 1.18e-04 | 8 | 11 | 2 | HP:0011479 | |
| HumanPheno | Cloverleaf skull | 1.18e-04 | 8 | 11 | 2 | HP:0002676 | |
| HumanPheno | Limbal stem cell deficiency | 1.18e-04 | 8 | 11 | 2 | HP:0032107 | |
| HumanPheno | Corneal erosion | 1.23e-04 | 48 | 11 | 3 | HP:0200020 | |
| HumanPheno | Palmoplantar cutis laxa | 1.51e-04 | 9 | 11 | 2 | HP:0007517 | |
| HumanPheno | Hypoplasia of the epiglottis | 1.89e-04 | 10 | 11 | 2 | HP:0005349 | |
| HumanPheno | Abnormality of the middle phalanges of the toes | 2.31e-04 | 11 | 11 | 2 | HP:0010183 | |
| HumanPheno | Lacrimal duct aplasia | 2.31e-04 | 11 | 11 | 2 | HP:0007925 | |
| HumanPheno | Aplastic/hypoplastic lacrimal glands | 2.31e-04 | 11 | 11 | 2 | HP:0008038 | |
| HumanPheno | Abnormal fibula morphology | 2.64e-04 | 62 | 11 | 3 | HP:0002991 | |
| HumanPheno | Abnormality of the distal phalanx of the hallux | 2.77e-04 | 12 | 11 | 2 | HP:0010053 | |
| HumanPheno | Open angle glaucoma | 2.77e-04 | 12 | 11 | 2 | HP:0012108 | |
| HumanPheno | Aplasia/Hypoplasia of the Epiglottis | 3.26e-04 | 13 | 11 | 2 | HP:0010565 | |
| HumanPheno | Abnormal lacrimal gland morphology | 3.26e-04 | 13 | 11 | 2 | HP:0011482 | |
| HumanPheno | Excessive wrinkling of palmar skin | 3.26e-04 | 13 | 11 | 2 | HP:0007605 | |
| HumanPheno | Abnormality of the crus of the helix | 3.80e-04 | 14 | 11 | 2 | HP:0009895 | |
| HumanPheno | Duplication of phalanx of hallux | 3.80e-04 | 14 | 11 | 2 | HP:0010066 | |
| HumanPheno | Parietal foramina | 3.80e-04 | 14 | 11 | 2 | HP:0002697 | |
| HumanPheno | Duplication of phalanx of toe | 4.38e-04 | 15 | 11 | 2 | HP:0010181 | |
| HumanPheno | Recurrent corneal erosions | 4.38e-04 | 15 | 11 | 2 | HP:0000495 | |
| HumanPheno | Narrow internal auditory canal | 5.00e-04 | 16 | 11 | 2 | HP:0011386 | |
| HumanPheno | Abnormality of cartilage of external ear | 6.37e-04 | 18 | 11 | 2 | HP:3000022 | |
| HumanPheno | Alacrima | 6.37e-04 | 18 | 11 | 2 | HP:0000522 | |
| HumanPheno | Upper airway obstruction | 6.37e-04 | 18 | 11 | 2 | HP:0002781 | |
| HumanPheno | Lacrimal duct stenosis | 7.11e-04 | 19 | 11 | 2 | HP:0007678 | |
| HumanPheno | Ulnar bowing | 7.89e-04 | 20 | 11 | 2 | HP:0003031 | |
| HumanPheno | Keratitis | 7.94e-04 | 90 | 11 | 3 | HP:0000491 | |
| HumanPheno | Abnormality of the internal auditory canal | 9.57e-04 | 22 | 11 | 2 | HP:0011384 | |
| HumanPheno | Corneal ulceration | 9.57e-04 | 22 | 11 | 2 | HP:0012804 | |
| HumanPheno | Abnormality of cartilage morphology | 1.05e-03 | 23 | 11 | 2 | HP:0410007 | |
| HumanPheno | Abnormal epiglottis morphology | 1.05e-03 | 23 | 11 | 2 | HP:0005483 | |
| HumanPheno | Tooth malposition | 1.11e-03 | 418 | 11 | 5 | HP:0000692 | |
| HumanPheno | Corneal neovascularization | 1.24e-03 | 25 | 11 | 2 | HP:0011496 | |
| HumanPheno | Tarsal synostosis | 1.34e-03 | 26 | 11 | 2 | HP:0008368 | |
| HumanPheno | Abnormal salivary gland morphology | 1.34e-03 | 26 | 11 | 2 | HP:0010286 | |
| HumanPheno | Epiphora | 1.44e-03 | 27 | 11 | 2 | HP:0009926 | |
| HumanPheno | Decreased lacrimation | 1.44e-03 | 27 | 11 | 2 | HP:0000633 | |
| HumanPheno | Broad distal phalanx of finger | 1.44e-03 | 27 | 11 | 2 | HP:0009836 | |
| HumanPheno | Choanal stenosis | 1.55e-03 | 28 | 11 | 2 | HP:0000452 | |
| HumanPheno | Abnormal clavicle morphology | 1.66e-03 | 116 | 11 | 3 | HP:0000889 | |
| HumanPheno | Abnormality of the distal phalanges of the toes | 1.67e-03 | 29 | 11 | 2 | HP:0010182 | |
| HumanPheno | Abnormal parietal bone morphology | 1.67e-03 | 29 | 11 | 2 | HP:0002696 | |
| HumanPheno | Preaxial foot polydactyly | 1.78e-03 | 30 | 11 | 2 | HP:0001841 | |
| HumanPheno | Synostosis involving bones of the feet | 2.03e-03 | 32 | 11 | 2 | HP:0009140 | |
| HumanPheno | Synostosis involving bones of the lower limbs | 2.03e-03 | 32 | 11 | 2 | HP:0009138 | |
| HumanPheno | Coronal craniosynostosis | 2.03e-03 | 32 | 11 | 2 | HP:0004440 | |
| HumanPheno | Abnormality of the dentition | 2.08e-03 | 1030 | 11 | 7 | HP:0000164 | |
| HumanPheno | Abnormality of the elbow | 2.23e-03 | 282 | 11 | 4 | HP:0009811 | |
| HumanPheno | Anterior bulging of the globe | 2.25e-03 | 283 | 11 | 4 | HP:0000644 | |
| HumanPheno | Proptosis | 2.25e-03 | 283 | 11 | 4 | HP:0000520 | |
| HumanPheno | Hypoplasia of the maxilla | 2.31e-03 | 130 | 11 | 3 | HP:0000327 | |
| HumanPheno | Abnormal corneal epithelium morphology | 2.41e-03 | 132 | 11 | 3 | HP:0011495 | |
| HumanPheno | Mesomelia | 2.43e-03 | 35 | 11 | 2 | HP:0003027 | |
| HumanPheno | Aplasia/Hypoplasia of the maxilla | 2.46e-03 | 133 | 11 | 3 | HP:0009117 | |
| HumanPheno | Blepharospasm | 2.57e-03 | 36 | 11 | 2 | HP:0000643 | |
| HumanPheno | Bowed forearm bones | 2.57e-03 | 36 | 11 | 2 | HP:0003956 | |
| HumanPheno | Nasolacrimal duct obstruction | 2.57e-03 | 36 | 11 | 2 | HP:0000579 | |
| MousePheno | abnormal cranial synchondrosis | 2.34e-05 | 6 | 18 | 2 | MP:0030443 | |
| MousePheno | enlarged brain ventricles | 4.04e-05 | 156 | 18 | 4 | MP:0011380 | |
| MousePheno | abnormal brain ventricle size | 4.92e-05 | 164 | 18 | 4 | MP:0013229 | |
| MousePheno | decreased bone stiffness | 5.61e-05 | 9 | 18 | 2 | MP:0013639 | |
| MousePheno | abnormal long bone epiphyseal ossification zone morphology | 5.61e-05 | 9 | 18 | 2 | MP:0006399 | |
| MousePheno | abnormal cranial cartilage development | 5.61e-05 | 9 | 18 | 2 | MP:0030467 | |
| MousePheno | short basicranium | 7.00e-05 | 10 | 18 | 2 | MP:0030420 | |
| MousePheno | abnormal coronal suture morphology | 1.21e-04 | 13 | 18 | 2 | MP:0003840 | |
| MousePheno | abnormal bone stiffness | 1.21e-04 | 13 | 18 | 2 | MP:0013636 | |
| MousePheno | premature cranial suture closure | 1.41e-04 | 14 | 18 | 2 | MP:0000081 | |
| MousePheno | premature intramembranous bone ossification | 1.41e-04 | 14 | 18 | 2 | MP:0003418 | |
| MousePheno | premature craniofacial suture closure | 1.41e-04 | 14 | 18 | 2 | MP:0030435 | |
| MousePheno | enlarged lateral ventricles | 1.60e-04 | 84 | 18 | 3 | MP:0008535 | |
| MousePheno | translucent skin | 1.63e-04 | 15 | 18 | 2 | MP:0001201 | |
| MousePheno | enhanced osteoblast differentiation | 1.63e-04 | 15 | 18 | 2 | MP:0011710 | |
| MousePheno | abnormal synchondrosis | 1.86e-04 | 16 | 18 | 2 | MP:0004053 | |
| MousePheno | macrodontia | 1.86e-04 | 16 | 18 | 2 | MP:0030091 | |
| MousePheno | long incisors | 1.86e-04 | 16 | 18 | 2 | MP:0004831 | |
| MousePheno | perinatal lethality, complete penetrance | 1.87e-04 | 712 | 18 | 6 | MP:0011089 | |
| MousePheno | midface hypoplasia | 2.11e-04 | 17 | 18 | 2 | MP:0012085 | |
| MousePheno | increased cranium width | 2.64e-04 | 19 | 18 | 2 | MP:0000441 | |
| MousePheno | face hypoplasia | 2.64e-04 | 19 | 18 | 2 | MP:0030065 | |
| MousePheno | thin cerebral cortex | 2.68e-04 | 100 | 18 | 3 | MP:0006254 | |
| MousePheno | abnormal snout morphology | 2.79e-04 | 257 | 18 | 4 | MP:0000443 | |
| MousePheno | abnormal vertebral column morphology | 3.23e-04 | 787 | 18 | 6 | MP:0004703 | |
| MousePheno | abnormal incisor morphology | 3.55e-04 | 110 | 18 | 3 | MP:0005358 | |
| MousePheno | decreased cranium length | 3.56e-04 | 22 | 18 | 2 | MP:0011862 | |
| MousePheno | abnormal brain ventricle morphology | 4.19e-04 | 286 | 18 | 4 | MP:0000822 | |
| MousePheno | premature bone ossification | 5.00e-04 | 26 | 18 | 2 | MP:0003416 | |
| MousePheno | small frontal bone | 5.00e-04 | 26 | 18 | 2 | MP:0004377 | |
| MousePheno | small parietal bone | 5.39e-04 | 27 | 18 | 2 | MP:0004418 | |
| MousePheno | delayed bone ossification | 5.41e-04 | 127 | 18 | 3 | MP:0000060 | |
| MousePheno | abnormal corpus callosum morphology | 5.66e-04 | 129 | 18 | 3 | MP:0000780 | |
| MousePheno | abnormal palatine bone horizontal plate morphology | 5.80e-04 | 28 | 18 | 2 | MP:0004537 | |
| MousePheno | abnormal midface morphology | 5.80e-04 | 28 | 18 | 2 | MP:0030095 | |
| MousePheno | abnormal dorsal telencephalic commissure morphology | 6.05e-04 | 132 | 18 | 3 | MP:0008219 | |
| MousePheno | ocular hypertelorism | 6.23e-04 | 29 | 18 | 2 | MP:0001300 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 6.48e-04 | 1269 | 18 | 7 | MP:0011111 | |
| MousePheno | abnormal cerebral hemisphere morphology | 7.64e-04 | 599 | 18 | 5 | MP:0008540 | |
| MousePheno | abnormal presphenoid bone morphology | 8.08e-04 | 33 | 18 | 2 | MP:0004448 | |
| MousePheno | thin epidermis | 8.08e-04 | 33 | 18 | 2 | MP:0001218 | |
| MousePheno | decreased cranium height | 8.08e-04 | 33 | 18 | 2 | MP:0008525 | |
| MousePheno | abnormal sternum ossification | 1.02e-03 | 37 | 18 | 2 | MP:0008277 | |
| MousePheno | abnormal epidermis stratum basale morphology | 1.02e-03 | 37 | 18 | 2 | MP:0001231 | |
| MousePheno | small face | 1.02e-03 | 37 | 18 | 2 | MP:0030064 | |
| MousePheno | craniofacial phenotype | 1.04e-03 | 1372 | 18 | 7 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 1.04e-03 | 1372 | 18 | 7 | MP:0000428 | |
| MousePheno | decreased bone strength | 1.07e-03 | 38 | 18 | 2 | MP:0004991 | |
| MousePheno | abnormal brain commissure morphology | 1.08e-03 | 161 | 18 | 3 | MP:0002199 | |
| MousePheno | abnormal lateral ventricle morphology | 1.14e-03 | 164 | 18 | 3 | MP:0000823 | |
| MousePheno | respiratory failure | 1.16e-03 | 165 | 18 | 3 | MP:0001953 | |
| MousePheno | abnormal embryonic/fetal subventricular zone morphology | 1.25e-03 | 41 | 18 | 2 | MP:0004274 | |
| MousePheno | decreased respiration | 1.26e-03 | 170 | 18 | 3 | MP:0014274 | |
| MousePheno | decreased width of hypertrophic chondrocyte zone | 1.31e-03 | 42 | 18 | 2 | MP:0003409 | |
| MousePheno | abnormal face size | 1.31e-03 | 42 | 18 | 2 | MP:0030063 | |
| MousePheno | abnormal brain ventricular system morphology | 1.38e-03 | 393 | 18 | 4 | MP:0002200 | |
| MousePheno | impaired lung alveolus development | 1.43e-03 | 44 | 18 | 2 | MP:0006027 | |
| MousePheno | decreased osteoblast cell number | 1.50e-03 | 45 | 18 | 2 | MP:0004989 | |
| MousePheno | abnormal hyaline cartilage morphology | 1.57e-03 | 46 | 18 | 2 | MP:0006429 | |
| MousePheno | abnormal palatine bone morphology | 1.57e-03 | 46 | 18 | 2 | MP:0005249 | |
| MousePheno | malocclusion | 1.64e-03 | 47 | 18 | 2 | MP:0000120 | |
| MousePheno | abnormal nervous system tract morphology | 1.71e-03 | 189 | 18 | 3 | MP:0000778 | |
| MousePheno | abnormal lung alveolus development | 1.85e-03 | 50 | 18 | 2 | MP:0010995 | |
| MousePheno | abnormal cranial cartilage morphology | 1.85e-03 | 50 | 18 | 2 | MP:0030464 | |
| MousePheno | abnormal fibula morphology | 1.92e-03 | 51 | 18 | 2 | MP:0002187 | |
| MousePheno | abnormal palate bone morphology | 1.92e-03 | 51 | 18 | 2 | MP:0009891 | |
| MousePheno | misaligned teeth | 2.00e-03 | 52 | 18 | 2 | MP:0030540 | |
| MousePheno | abnormal head morphology | 2.09e-03 | 1120 | 18 | 6 | MP:0000432 | |
| MousePheno | abnormal brain white matter morphology | 2.19e-03 | 206 | 18 | 3 | MP:0008026 | |
| MousePheno | perinatal lethality | 2.19e-03 | 1130 | 18 | 6 | MP:0002081 | |
| Domain | FGF_rcpt_fam | 6.53e-06 | 4 | 20 | 2 | IPR016248 | |
| Domain | Bromodomain_CS | 3.49e-04 | 26 | 20 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 7.09e-04 | 37 | 20 | 2 | PS00633 | |
| Domain | Bromodomain | 7.48e-04 | 38 | 20 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 8.71e-04 | 41 | 20 | 2 | PS50014 | |
| Domain | BROMO | 9.14e-04 | 42 | 20 | 2 | SM00297 | |
| Domain | Bromodomain | 9.14e-04 | 42 | 20 | 2 | IPR001487 | |
| Domain | - | 9.14e-04 | 42 | 20 | 2 | 1.20.920.10 | |
| Domain | TyrKc | 3.95e-03 | 88 | 20 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.95e-03 | 88 | 20 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.77e-03 | 97 | 20 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.77e-03 | 97 | 20 | 2 | IPR008266 | |
| Domain | Pkinase_Tyr | 8.29e-03 | 129 | 20 | 2 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.44e-03 | 138 | 20 | 2 | IPR001245 | |
| Domain | AAA+_ATPase | 1.02e-02 | 144 | 20 | 2 | IPR003593 | |
| Domain | AAA | 1.02e-02 | 144 | 20 | 2 | SM00382 | |
| Domain | I-set | 1.73e-02 | 190 | 20 | 2 | PF07679 | |
| Domain | Ig_I-set | 1.73e-02 | 190 | 20 | 2 | IPR013098 | |
| Domain | - | 2.24e-02 | 218 | 20 | 2 | 1.10.10.10 | |
| Domain | Ig_sub2 | 2.58e-02 | 235 | 20 | 2 | IPR003598 | |
| Domain | IGc2 | 2.58e-02 | 235 | 20 | 2 | SM00408 | |
| Domain | WHTH_DNA-bd_dom | 2.72e-02 | 242 | 20 | 2 | IPR011991 | |
| Pathway | WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS | 2.64e-04 | 23 | 15 | 2 | M39862 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.68e-04 | 313 | 15 | 4 | M27867 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 3.13e-04 | 25 | 15 | 2 | M47934 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 4.83e-04 | 31 | 15 | 2 | M47396 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 6.16e-04 | 35 | 15 | 2 | M47379 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.16e-03 | 48 | 15 | 2 | M26916 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 1.26e-03 | 50 | 15 | 2 | M48087 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.46e-03 | 54 | 15 | 2 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.46e-03 | 54 | 15 | 2 | M620 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 1.52e-03 | 55 | 15 | 2 | M47952 | |
| Pathway | PID_FGF_PATHWAY | 1.52e-03 | 55 | 15 | 2 | M276 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 1.99e-03 | 63 | 15 | 2 | M39623 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 1.99e-03 | 63 | 15 | 2 | M635 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.19e-03 | 252 | 15 | 3 | MM15585 | |
| Pubmed | Fibroblast growth factor receptor 3 is a negative regulator of bone growth. | 3.82e-07 | 2 | 22 | 2 | 8601314 | |
| Pubmed | Activation of FGF receptors by mutations in the transmembrane domain. | 3.82e-07 | 2 | 22 | 2 | 9136983 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 11325814 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 33853673 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 35303508 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 23325524 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 32822871 | ||
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 34993201 | ||
| Pubmed | Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma. | 3.82e-07 | 2 | 22 | 2 | 23786770 | |
| Pubmed | 3.82e-07 | 2 | 22 | 2 | 21152424 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 31189094 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 30202094 | ||
| Pubmed | Mutations in different components of FGF signaling in LADD syndrome. | 1.15e-06 | 3 | 22 | 2 | 16501574 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 20301628 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 8382556 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 14732692 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 31830366 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 12032146 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 26465941 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 33433858 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 30755670 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 9286594 | ||
| Pubmed | Tracheal cartilaginous sleeves in children with syndromic craniosynostosis. | 1.15e-06 | 3 | 22 | 2 | 27228464 | |
| Pubmed | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. | 1.15e-06 | 3 | 22 | 2 | 24850843 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 7896824 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 8619928 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 23185502 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 29097598 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 19728793 | ||
| Pubmed | Enriched Environment Promotes Adult Hippocampal Neurogenesis through FGFRs. | 1.15e-06 | 3 | 22 | 2 | 33637561 | |
| Pubmed | Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer. | 1.15e-06 | 3 | 22 | 2 | 24898159 | |
| Pubmed | Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. | 1.15e-06 | 3 | 22 | 2 | 9585583 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18216705 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 10704861 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 17414280 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9212826 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 27154171 | ||
| Pubmed | Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. | 2.29e-06 | 4 | 22 | 2 | 23393200 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 9664689 | ||
| Pubmed | Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. | 2.29e-06 | 4 | 22 | 2 | 17343269 | |
| Pubmed | Astrocyte activation is suppressed in both normal and injured brain by FGF signaling. | 2.29e-06 | 4 | 22 | 2 | 25002516 | |
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 2.29e-06 | 4 | 22 | 2 | 12373339 | |
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 2.29e-06 | 4 | 22 | 2 | 36142417 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 11759058 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 32858001 | ||
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 2.29e-06 | 4 | 22 | 2 | 18776942 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 15105428 | ||
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 2.29e-06 | 4 | 22 | 2 | 17304337 | |
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 16210019 | ||
| Pubmed | 2.29e-06 | 4 | 22 | 2 | 12644244 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 27206683 | ||
| Pubmed | Nectin-1 binds and signals through the fibroblast growth factor receptor. | 3.82e-06 | 5 | 22 | 2 | 22955284 | |
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 3.82e-06 | 5 | 22 | 2 | 15987787 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 28094278 | ||
| Pubmed | Expression and biological activity of mouse fibroblast growth factor-9. | 3.82e-06 | 5 | 22 | 2 | 8576175 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 3.82e-06 | 5 | 22 | 2 | 27078042 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 9300656 | ||
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 19696444 | ||
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 3.82e-06 | 5 | 22 | 2 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 3.82e-06 | 5 | 22 | 2 | 21633168 | |
| Pubmed | FGF21 signalling pathway and metabolic traits - genetic association analysis. | 3.82e-06 | 5 | 22 | 2 | 20717167 | |
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 3.82e-06 | 5 | 22 | 2 | 9771645 | |
| Pubmed | 3.82e-06 | 5 | 22 | 2 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 3.82e-06 | 5 | 22 | 2 | 11566361 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 19232523 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 29720668 | ||
| Pubmed | Distinct genetic loci control development of benign and malignant skin tumours in mice. | 5.72e-06 | 6 | 22 | 2 | 7670492 | |
| Pubmed | Gyrification of the cerebral cortex requires FGF signaling in the mammalian brain. | 5.72e-06 | 6 | 22 | 2 | 29132503 | |
| Pubmed | Discrete domains of gene expression in germinal layers distinguish the development of gyrencephaly. | 5.72e-06 | 6 | 22 | 2 | 25916825 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 10572038 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 38056728 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 19812598 | ||
| Pubmed | The complex morphology of reactive astrocytes controlled by fibroblast growth factor signaling. | 5.72e-06 | 6 | 22 | 2 | 24796693 | |
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 9010207 | ||
| Pubmed | 5.72e-06 | 6 | 22 | 2 | 16365308 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 5.72e-06 | 6 | 22 | 2 | 24026051 | |
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 5.72e-06 | 6 | 22 | 2 | 16436388 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 16772167 | ||
| Pubmed | Fibroblast growth factor signaling regulates Dach1 expression during skeletal development. | 8.01e-06 | 7 | 22 | 2 | 12203718 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 8959336 | ||
| Pubmed | FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells. | 8.01e-06 | 7 | 22 | 2 | 17192470 | |
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 8.01e-06 | 7 | 22 | 2 | 20131355 | |
| Pubmed | 8.01e-06 | 7 | 22 | 2 | 27133954 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 28389228 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 17623664 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 19218784 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 12966207 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 14602678 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 18187602 | ||
| Pubmed | 1.07e-05 | 8 | 22 | 2 | 12737212 | ||
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 1.07e-05 | 8 | 22 | 2 | 16989989 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.22e-05 | 71 | 22 | 3 | 28319113 | |
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 31175212 | ||
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 11335076 | ||
| Pubmed | Autocrine and paracrine mechanisms regulating primordial germ cell proliferation. | 1.37e-05 | 9 | 22 | 2 | 15039943 | |
| Pubmed | 1.37e-05 | 9 | 22 | 2 | 15229180 | ||
| Pubmed | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. | 1.37e-05 | 9 | 22 | 2 | 15830353 | |
| Pubmed | Dynamic activation of Wnt, Fgf, and Hh signaling during soft palate development. | 1.37e-05 | 9 | 22 | 2 | 31613912 | |
| Pubmed | FGF9 can induce endochondral ossification in cranial mesenchyme. | 1.37e-05 | 9 | 22 | 2 | 16504022 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 1.37e-05 | 9 | 22 | 2 | 10751173 | |
| Interaction | FGF6 interactions | 2.38e-05 | 7 | 22 | 2 | int:FGF6 | |
| Interaction | FGF18 interactions | 2.38e-05 | 7 | 22 | 2 | int:FGF18 | |
| Interaction | FGF5 interactions | 3.17e-05 | 8 | 22 | 2 | int:FGF5 | |
| Interaction | FGF23 interactions | 3.17e-05 | 8 | 22 | 2 | int:FGF23 | |
| Interaction | CRLF2 interactions | 3.90e-05 | 61 | 22 | 3 | int:CRLF2 | |
| Interaction | DENND10P1 interactions | 4.08e-05 | 9 | 22 | 2 | int:DENND10P1 | |
| Interaction | CEP192 interactions | 5.11e-05 | 192 | 22 | 4 | int:CEP192 | |
| Interaction | KLB interactions | 7.46e-05 | 12 | 22 | 2 | int:KLB | |
| Interaction | KL interactions | 1.03e-04 | 14 | 22 | 2 | int:KL | |
| Interaction | SEC24B interactions | 1.21e-04 | 240 | 22 | 4 | int:SEC24B | |
| Interaction | FGF7 interactions | 1.35e-04 | 16 | 22 | 2 | int:FGF7 | |
| Interaction | FGF9 interactions | 1.35e-04 | 16 | 22 | 2 | int:FGF9 | |
| Interaction | NCKAP5L interactions | 2.03e-04 | 106 | 22 | 3 | int:NCKAP5L | |
| Interaction | CENPE interactions | 2.03e-04 | 106 | 22 | 3 | int:CENPE | |
| Interaction | NECTIN1 interactions | 2.59e-04 | 22 | 22 | 2 | int:NECTIN1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 2.44e-03 | 153 | 22 | 2 | chr2q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 3.46e-03 | 183 | 22 | 2 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q26 | 4.40e-03 | 207 | 22 | 2 | chr10q26 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.92e-04 | 40 | 15 | 2 | 321 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.67e-03 | 161 | 15 | 2 | 593 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 153 | 21 | 3 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 153 | 21 | 3 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.90e-05 | 153 | 21 | 3 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 162 | 21 | 3 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 162 | 21 | 3 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.94e-05 | 172 | 21 | 3 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.75e-05 | 186 | 21 | 3 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.03e-05 | 188 | 21 | 3 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.03e-05 | 188 | 21 | 3 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-05 | 189 | 21 | 3 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-05 | 189 | 21 | 3 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.18e-05 | 189 | 21 | 3 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-05 | 190 | 21 | 3 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 191 | 21 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 191 | 21 | 3 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 191 | 21 | 3 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 191 | 21 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 191 | 21 | 3 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 191 | 21 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.91e-05 | 194 | 21 | 3 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.91e-05 | 194 | 21 | 3 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 194 | 21 | 3 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.02e-04 | 196 | 21 | 3 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.02e-04 | 196 | 21 | 3 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 197 | 21 | 3 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 197 | 21 | 3 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 197 | 21 | 3 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | medial-2-Epithelial-Basal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-04 | 199 | 21 | 3 | 10af93596cc6d5da4cf5052707ff5f7fc347dc84 | |
| ToppCell | medial-Epithelial-Basal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-04 | 199 | 21 | 3 | fa7584e3cc0f8cbdd6a76c6a0faee26b0922c4ae | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | medial-Epithelial-Basal-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-04 | 199 | 21 | 3 | fc37f8868417308fb4410684d0d1e506cec30f35 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-04 | 199 | 21 | 3 | dadee9fc6ce4f4bdb19d29326889316443dda0cb | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 200 | 21 | 3 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-04 | 200 | 21 | 3 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 200 | 21 | 3 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.08e-04 | 200 | 21 | 3 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | B_cell_maturation-pre-B|World / Lineage and Cell class | 1.08e-04 | 200 | 21 | 3 | acb9ad7e3c05ec38e9700fb27b6eed8eaa565689 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a6-Slc17a7.Fezf2.3110035E14Rik_(Deep_layer_pyramidal_cells-Layer_5b)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.20e-04 | 72 | 21 | 2 | 4f424d2d4e62f212881189f3e99cec22048438f0 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a6-Slc17a7-Slc17a8.Fezf2.Slc17a8_(Deep_layer_pyramidal_cells-Layer_5b)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.49e-04 | 74 | 21 | 2 | e6c8b8046948a205e996e585f983fd0af80d5491 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.75e-04 | 88 | 21 | 2 | fcc15c5c30517c63a835b28627c5f779d9bcd17e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7-Slc17a8.Syt6-Lancl3_(Cortical_Subplate_pyramidal_cells)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.75e-04 | 88 | 21 | 2 | 7838c65160cf81c02b923fc34f566c0610c8d81b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.03e-04 | 95 | 21 | 2 | ffbf3e362384c87b9db690ed39cd215e1f68375c | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-03 | 116 | 21 | 2 | cf4e3c34570f57502ec524881d351ef8e47976d2 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-03 | 127 | 21 | 2 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-03 | 131 | 21 | 2 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_-_proliferative|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.83e-03 | 136 | 21 | 2 | 96370f0e3abf1c9ec7a91595b5d0f97ac2ab4b78 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-03 | 141 | 21 | 2 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-03 | 144 | 21 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-03 | 145 | 21 | 2 | fd02d55755c35288a42ab08a82450b370aad35a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-03 | 145 | 21 | 2 | 2eebf2294c53f081d3b0169071388e477a195218 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.08e-03 | 145 | 21 | 2 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.11e-03 | 146 | 21 | 2 | 7748277cf2f12e2930d4f5a22247ab9bc266a954 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-TRAM-3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.14e-03 | 147 | 21 | 2 | 50a855aa7f214c3be8ac46a22adf9bc9dd0285db | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-03 | 149 | 21 | 2 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-03 | 149 | 21 | 2 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-03 | 149 | 21 | 2 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | (00)_Basal|World / shred by cell type and Timepoint | 2.20e-03 | 149 | 21 | 2 | 49e39206f37cee124ca4763c79425b805e50624b | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.20e-03 | 149 | 21 | 2 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-03 | 150 | 21 | 2 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-03 | 151 | 21 | 2 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-03 | 155 | 21 | 2 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-03 | 155 | 21 | 2 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-03 | 156 | 21 | 2 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.40e-03 | 156 | 21 | 2 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.40e-03 | 156 | 21 | 2 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-03 | 157 | 21 | 2 | 803af734d7f775d294391e2b84e472a732e18cef | |
| ToppCell | PND07-28-samps-Lymphocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.43e-03 | 157 | 21 | 2 | 105f2711d7bae3be36714954e103c61cf021f957 | |
| ToppCell | PND07-28-samps-Lymphocyte-T_cells|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.43e-03 | 157 | 21 | 2 | f3b4cde52423246ae6fc4924cd1ee502cf6c009c | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-03 | 157 | 21 | 2 | 9aa5304a9704da6dd4eda7d6940494b00e38b2e8 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK_CD56bright|Leuk-UTI / Disease, Lineage and Cell Type | 2.43e-03 | 157 | 21 | 2 | db0057741d06e212a9543cb4b011659b79efeafc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.43e-03 | 157 | 21 | 2 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | frontal_cortex-Non-neuronal-astrocyte-Astro|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-03 | 157 | 21 | 2 | 0551442ae14685d8fe5729e3960c6324b1e05e4d | |
| ToppCell | Entopeduncular|World / BrainAtlas - Mouse McCarroll V32 | 2.52e-03 | 160 | 21 | 2 | 833763c8608de4ee6003b8fb682aa9c83d7dea9b | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.59e-03 | 162 | 21 | 2 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-03 | 162 | 21 | 2 | a957c7e347189b72fbd47db3075bb5e879a21c67 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.65e-03 | 164 | 21 | 2 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-03 | 165 | 21 | 2 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.68e-03 | 165 | 21 | 2 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-03 | 166 | 21 | 2 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-03 | 167 | 21 | 2 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-03 | 168 | 21 | 2 | c833e3311af2582787d3ff2ad59d802fff865f8f | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.78e-03 | 168 | 21 | 2 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-03 | 168 | 21 | 2 | 100ab6d36592b61f4db9f8cb90c48afac016d679 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-03 | 168 | 21 | 2 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-03 | 169 | 21 | 2 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.81e-03 | 169 | 21 | 2 | aec97583b23112060437b619cb429dc32f29285f | |
| ToppCell | droplet-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-03 | 169 | 21 | 2 | 53690d6f9712b54aa99a0408aae930d64ae478e5 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-03 | 170 | 21 | 2 | 53fd50c9a27d47662fbcbd7e9e9837f72ac448c5 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-03 | 170 | 21 | 2 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-03 | 170 | 21 | 2 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 5.34e-06 | 4 | 22 | 2 | ctd:C568950 | |
| Drug | Palifermin | 1.33e-05 | 6 | 22 | 2 | DB00039 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HG-U133A | 3.12e-05 | 191 | 22 | 4 | 381_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 3.52e-05 | 197 | 22 | 4 | 6863_UP | |
| Drug | PD 166285 | 5.85e-05 | 12 | 22 | 2 | CID005311382 | |
| Drug | crisamicin A | 6.91e-05 | 13 | 22 | 2 | CID000125855 | |
| Drug | difluoroboron | 7.09e-05 | 84 | 22 | 3 | CID000139622 | |
| Disease | Isolated coronal synostosis | 4.36e-07 | 2 | 20 | 2 | cv:CN043619 | |
| Disease | Lacrimoauriculodentodigital syndrome | 1.31e-06 | 3 | 20 | 2 | C0265269 | |
| Disease | Saethre-Chotzen Syndrome | 1.31e-06 | 3 | 20 | 2 | C0175699 | |
| Disease | Congenital hypoplasia of radius | 1.31e-06 | 3 | 20 | 2 | C0685381 | |
| Disease | Levy-Hollister syndrome | 1.31e-06 | 3 | 20 | 2 | cv:C0265269 | |
| Disease | TWIST1-related craniosynostosis | 2.62e-06 | 4 | 20 | 2 | cv:C4551902 | |
| Disease | Congenital small ears | 2.79e-06 | 41 | 20 | 3 | C0152423 | |
| Disease | bone disease (implicated_via_orthology) | 4.36e-06 | 5 | 20 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Craniosynostosis syndrome | 9.15e-06 | 7 | 20 | 2 | cv:C0010278 | |
| Disease | craniosynostosis (is_implicated_in) | 2.87e-05 | 12 | 20 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | Brachycephaly | 5.90e-05 | 17 | 20 | 2 | C0221356 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.19e-04 | 24 | 20 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.19e-04 | 24 | 20 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.40e-04 | 26 | 20 | 2 | C0206698 | |
| Disease | Cleft upper lip | 3.19e-04 | 39 | 20 | 2 | C0008924 | |
| Disease | Cleft palate, isolated | 3.70e-04 | 42 | 20 | 2 | C1837218 | |
| Disease | high grade glioma (implicated_via_orthology) | 4.06e-04 | 44 | 20 | 2 | DOID:3070 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | 6.08e-04 | 1069 | 20 | 5 | EFO_0004346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HMLKLAMDLKGKMPN | 896 | Q13523 | |
| AVDEMHMSLPKMKKD | 321 | Q8N1M1 | |
| MQEAKRMKHKADAMV | 981 | P51826 | |
| AKEAMAMGKLHKEMG | 266 | Q6NSW5 | |
| KAKEERRMDQMMPGK | 181 | Q03989 | |
| SGEKMAHMEKELQKM | 476 | Q96G01 | |
| EKDLRLHEYMKMMGV | 1091 | Q86UK0 | |
| HMMLMKAMEARKKAE | 1011 | Q9UIF8 | |
| EHDHRKRMGLKMLMM | 281 | P08574 | |
| EMKKMHEGDLAMALV | 201 | Q96SN8 | |
| LVSEMEMMKMIGKHK | 531 | P21802 | |
| KKPMDMEKIRSHMMA | 701 | Q86U86 | |
| RLKMEGHEAMERLKM | 31 | Q8WXI9 | |
| KDMMRKLEKHMTAEK | 261 | Q99741 | |
| DLVSEMEMMKMIGKH | 521 | P22607 | |
| AKEAMAMGKLHKEMG | 266 | Q8TCE6 | |
| HENSFMKMLRSKMGK | 86 | Q86YR6 | |
| IMKDMMKLELDLHGL | 346 | Q8TBY8 | |
| YSKEHMKKMMKDLEG | 236 | Q13586 | |
| MKKMMKDLEGLHRAE | 241 | Q13586 | |
| EERREHVAKMKKMEM | 341 | Q16181 | |
| DEEMEGSNMKHRLMK | 566 | Q70Z35 | |
| HMGRGREEAIMKMVK | 196 | Q9H8U3 | |
| MEVKMKEMKGSIRHL | 271 | Q96EK4 |